Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat ERK1 + ERK2 ELISA Kit (AC3903)
Cat.#: ASET-2492
Specifications
Description Rat ERK1 + ERK2 ELISA Kit allows for the in vitro quantitative determination of rat ERK1 + ERK2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2353 Human Insulin ELISA Kit (AC3764) Quantitative inquiry ASET-1930 Human CDNF ELISA Kit (AC3341) Quantitative inquiry ASET-2431 Estradiol ELISA Kit (AC3842) Quantitative inquiry ASET-1947 Human Wnt3a ELISA Kit (AC3358) Quantitative inquiry ASET-1466 Human PACRG ELISA Kit (AC2877) Quantitative inquiry ASET-1140 Human MT3 ELISA Kit (AC2551) Quantitative inquiry ASET-2318 Human Semaphorin 3A ELISA Kit (AC3729) Quantitative inquiry ASET-1309 Human Plasminogen Activator ELISA Kit (AC2720) Quantitative inquiry ASET-2088 Canine Adenosine A1 Receptor ELISA Kit (AC3499) Quantitative inquiry ASET-2249 Mouse Pcsk1n ELISA Kit (AC3660) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket